What concerns do you have about the transition to generic biotech seeds from a grower/farmer or consumer perspective? What opportunities might this present for farmers and seed producers?
How can we continue innovation and ensurea seamless transistion of biotech products from the current patent holder to the open market?
What policy suggestions do you have on this issue?